Prelude Capital Management, LLC Kezar Life Sciences, Inc. Transaction History
Prelude Capital Management, LLC
- $1.39 Billion
- Q2 2024
A detailed history of Prelude Capital Management, LLC transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 18,550 shares of KZR stock, worth $10,017. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,550
Previous 100,801
81.6%
Holding current value
$10,017
Previous $90,000
87.78%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding KZR
# of Institutions
83Shares Held
39.6MCall Options Held
3.2KPut Options Held
700-
Suvretta Capital Management, LLC New York, NY7.17MShares$3.87 Million0.18% of portfolio
-
Avidity Partners Management LP Dallas, TX5.03MShares$2.71 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.74MShares$1.48 Million0.0% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L32.05MShares$1.11 Million0.18% of portfolio
-
Orbimed Advisors LLC San Diego, CA1.93MShares$1.04 Million0.03% of portfolio
About Kezar Life Sciences, Inc.
- Ticker KZR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,369,504
- Market Cap $36.9M
- Description
- Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...